The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22502250 JP XVIIUltraviolet-visible Reference Spectra

Butropium Bromide 2

Cadralazine

Calcitonin Salmon

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22512251JP XVII Ultraviolet-visible Reference Spectra

Calcium Folinate

Camostat Mesilate

Candesartan Cilexetil

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22522252 JP XVIIUltraviolet-visible Reference Spectra

Carbamazepine

Carbazochrome Sodium Sulfonate Hydrate

Carbidopa Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22532253JP XVII Ultraviolet-visible Reference Spectra

Carmofur

Carteolol Hydrochloride

Carumonam Sodium

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22542254 JP XVIIUltraviolet-visible Reference Spectra

Carvedilol

Cefaclor

Cefadroxil

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22552255JP XVII Ultraviolet-visible Reference Spectra

Cefalexin

Cefalotin Sodium

Cefatrizine Propylene Glycolate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22562256 JP XVIIUltraviolet-visible Reference Spectra

Cefazolin Sodium

Cefazolin Sodium Hydrate

Cefbuperazone Sodium

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22572257JP XVII Ultraviolet-visible Reference Spectra

Cefcapene Pivoxil Hydrochloride Hydrate

Cefditoren Pivoxil

Cefixime Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22582258 JP XVIIUltraviolet-visible Reference Spectra

Cefmenoxime Hydrochloride

Cefmetazole Sodium

Cefminox Sodium Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22592259JP XVII Ultraviolet-visible Reference Spectra

Cefodizime Sodium

Cefoperazone Sodium

Cefotaxime Sodium

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22602260 JP XVIIUltraviolet-visible Reference Spectra

Cefotetan

Cefotiam Hexetil Hydrochloride

Cefotiam Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22612261JP XVII Ultraviolet-visible Reference Spectra

Cefpiramide Sodium

Cefpodoxime Proxetil

Cefroxadine Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22622262 JP XVIIUltraviolet-visible Reference Spectra

Cefsulodin Sodium

Ceftazidime Hydrate

Cefteram Pivoxil

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22632263JP XVII Ultraviolet-visible Reference Spectra

Ceftibuten Hydrate

Ceftizoxime Sodium

Ceftriaxone Sodium Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22642264 JP XVIIUltraviolet-visible Reference Spectra

Cefuroxime Axetil

Cetirizine Hydrochloride

Cetotiamine Hydrochloride Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22652265JP XVII Ultraviolet-visible Reference Spectra

Cetraxate Hydrochloride

Chloramphenicol

Chloramphenicol Palmitate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22662266 JP XVIIUltraviolet-visible Reference Spectra

Chloramphenicol Sodium Succinate

Chlordiazepoxide

Chlorphenesin Carbamate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22672267JP XVII Ultraviolet-visible Reference Spectra

Chlorpheniramine Maleate

d-Chlorpheniramine Maleate

Chlorpropamide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22682268 JP XVIIUltraviolet-visible Reference Spectra

Cibenzoline Succinate

Cilnidipine

Cilostazol

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22692269JP XVII Ultraviolet-visible Reference Spectra

Cinoxacin

Cisplatin

Citicoline

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22702270 JP XVIIUltraviolet-visible Reference Spectra

Clebopride Malate

Clinofibrate

Clocapramine Hydrochloride Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22712271JP XVII Ultraviolet-visible Reference Spectra

Clofedanol Hydrochloride

Clofibrate 1

Clofibrate 2

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22722272 JP XVIIUltraviolet-visible Reference Spectra

Clomifene Citrate

Clomipramine Hydrochloride

Clonazepam

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22732273JP XVII Ultraviolet-visible Reference Spectra

Clonidine Hydrochloride

Cloperastine Hydrochloride 1

Cloperastine Hydrochloride 2

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22742274 JP XVIIUltraviolet-visible Reference Spectra

Clopidogrel Sulfate

Clorazepate Dipotassium

Clotiazepam

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22752275JP XVII Ultraviolet-visible Reference Spectra

Clotrimazole

Cloxacillin Sodium Hydrate

Cloxazolam

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22762276 JP XVIIUltraviolet-visible Reference Spectra

Cocaine Hydrochloride 1

Cocaine Hydrochloride 2

Codeine Phosphate Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22772277JP XVII Ultraviolet-visible Reference Spectra

Colchicine

Cortisone Acetate

Croconazole Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22782278 JP XVIIUltraviolet-visible Reference Spectra

Cyanocobalamin

Cyproheptadine Hydrochloride Hydrate

Cytarabine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22792279JP XVII Ultraviolet-visible Reference Spectra

Danazol

Dantrolene Sodium Hydrate

Daunorubicin Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22802280 JP XVIIUltraviolet-visible Reference Spectra

Demethylchlortetracycline Hydrochloride

Dexamethasone

Dextromethorphan Hydrobromide Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22812281JP XVII Ultraviolet-visible Reference Spectra

Diazepam

Dibucaine Hydrochloride

Diclofenamide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22822282 JP XVIIUltraviolet-visible Reference Spectra

Dicloxacillin Sodium Hydrate

Diflucortolone Valerate

Dihydrocodeine Phosphate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22832283JP XVII Ultraviolet-visible Reference Spectra

Dihydroergotamine Mesilate

Dilazep Hydrochloride Hydrate

Diltiazem Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22842284 JP XVIIUltraviolet-visible Reference Spectra

Dimemorfan Phosphate

Dimorpholamine

Dinoprost

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22852285JP XVII Ultraviolet-visible Reference Spectra

Diphenhydramine Hydrochloride

Dipyridamole

Disopyramide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22862286 JP XVIIUltraviolet-visible Reference Spectra

Distigmine Bromide

Disulfiram

Docetaxel Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22872287JP XVII Ultraviolet-visible Reference Spectra

Domperidone

Donepezil Hydrochloride

Dopamine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22882288 JP XVIIUltraviolet-visible Reference Spectra

Dorzolamide Hydrochloride

Doxapram Hydrochloride Hydrate

Doxazosin Mesilate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22892289JP XVII Ultraviolet-visible Reference Spectra

Doxifluridine

Doxorubicin Hydrochloride

Droperidol

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22902290 JP XVIIUltraviolet-visible Reference Spectra

Droxidopa

Dydrogesterone

Ebastine